Nifty
Sensex
:
:
23465.60
76992.77
66.70 (0.29%)
181.87 (0.24%)

Pharmaceuticals & Drugs - Domestic

Rating :
73/99

BSE: 506820 | NSE: ASTRAZEN

6458.55
14-Jun-2024
  • Open
  • High
  • Low
  • Previous Close
  •  6320.00
  •  6625.00
  •  6320.00
  •  6373.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  14503
  •  940.31
  •  7220.95
  •  3575.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 16,145.00
  • 99.96
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 15,639.16
  • 0.37%
  • 22.68

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 1.37%
  • 16.34%
  • FII
  • DII
  • Others
  • 2.73%
  • 3.75%
  • 0.81%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.78
  • 6.61
  • 7.23

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 18.29
  • 4.04

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 12.77
  • 2.10

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 104.93
  • 96.78
  • 94.91

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.60
  • 18.60
  • 16.61

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 58.69
  • 58.52
  • 56.38

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • Astrazeneca Pharma I - Quarterly Results
    27th May 2024, 17:40 PM

    Read More
  • AstraZeneca Pharma gets nod to import for sale, distribution of Trastuzumab deruxtecan lyophilized powder
    27th Mar 2024, 12:00 PM

    The company has received permission from the Central Drugs Standard Control Organisation

    Read More
  • AstraZeneca Pharma India, Mankind Pharma enter into agreement
    11th Mar 2024, 17:15 PM

    AstraZeneca will retain the intellectual property rights to budesonide and formoterol fumarate dihydrate and will continue to be the Marketing Authorisation Holder and import license

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.